Suppr超能文献

病例对照研究在识别新型致畸物中的应用。

Case-control studies for identifying novel teratogens.

机构信息

Slone Epidemiology Center at Boston University, 1010 Commonwealth Avenue, Boston, MA 02215, USA.

出版信息

Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):201-8. doi: 10.1002/ajmg.c.30307. Epub 2011 Jul 15.

Abstract

The case-control study design offers an operationally efficient approach to measuring an association between an exposure and an outcome, especially when the outcome is rare, as is true for specific birth defects. For example, instead of following 50,000 pregnant women to have sufficient statistical power to identify a doubling in risk of oral clefts associated with a common exposure (e.g., cigarette smoking), 75 cases and 3 controls per case could be studied with equal statistical power. Examples of case sources include hospital or clinical series, or birth defect registries. For validity, control subjects should represent the population base of the cases, which can be difficult to identify for non-population-based case groups. Case-control studies typically rely on retrospective exposure measurement, which presents a major challenge and sets up the possibility of recall bias. Approaches are discussed to keep sources of bias to a minimum, including recall, non-differential information, and selection biases. Case-control studies can play an important role in this process for both hypothesis-generation and hypothesis-testing of potential teratogens. Examples of case-control studies and their contributions to the field are presented. © 2011 Wiley-Liss, Inc.

摘要

病例对照研究设计为测量暴露与结果之间的关联提供了一种操作效率高的方法,特别是当结果罕见时,例如特定的出生缺陷。例如,与其跟踪 50,000 名孕妇以获得足够的统计能力来识别与常见暴露(例如吸烟)相关的口腔裂风险增加一倍,不如对每个病例的 75 例病例和 3 例对照进行研究,以获得相同的统计能力。病例来源的例子包括医院或临床系列,或出生缺陷登记处。为了确保有效性,对照应代表病例的人群基础,这对于非基于人群的病例组来说可能难以确定。病例对照研究通常依赖于回顾性暴露测量,这带来了重大挑战,并有可能产生回忆偏倚。讨论了一些方法来将偏差源降至最低,包括回忆、非差异信息和选择偏差。病例对照研究可以在这一过程中为潜在致畸物的假说产生和检验发挥重要作用。介绍了病例对照研究的例子及其对该领域的贡献。©2011 Wiley-Liss,Inc.

相似文献

1
Case-control studies for identifying novel teratogens.
Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):201-8. doi: 10.1002/ajmg.c.30307. Epub 2011 Jul 15.
2
Findings on potential teratogens from a case-control study in Western Australia.
Aust N Z J Obstet Gynaecol. 2003 Dec;43(6):443-7. doi: 10.1046/j.0004-8666.2003.00127.x.
3
Human teratogens, prenatal mortality, and selection bias.
Am J Epidemiol. 1989 Aug;130(2):361-70. doi: 10.1093/oxfordjournals.aje.a115342.
4
Methodological approaches to evaluate teratogenic risk using birth defect registries: advantages and disadvantages.
PLoS One. 2012;7(10):e46626. doi: 10.1371/journal.pone.0046626. Epub 2012 Oct 3.
6
When the right (Drug) should be left: Prenatal drug exposure and heterotaxy syndrome.
Birth Defects Res A Clin Mol Teratol. 2016 Jul;106(7):573-9. doi: 10.1002/bdra.23497. Epub 2016 Mar 15.
7
Associations between maternal periconceptional exposure to secondhand tobacco smoke and major birth defects.
Am J Obstet Gynecol. 2016 Nov;215(5):613.e1-613.e11. doi: 10.1016/j.ajog.2016.07.022. Epub 2016 Jul 18.
8
Update on new developments in the study of human teratogens.
Teratology. 2002 Apr;65(4):153-61. doi: 10.1002/tera.10032.
9
Selection of controls in case-control studies on maternal medication use and risk of birth defects.
Birth Defects Res A Clin Mol Teratol. 2007 Sep;79(9):652-6. doi: 10.1002/bdra.20388.

引用本文的文献

2
Interpreting the pharmacoepidemiology literature in obstetrical studies: A guide for clinicians.
Semin Perinatol. 2020 Apr;44(3):151225. doi: 10.1016/j.semperi.2020.151225. Epub 2020 Feb 28.
6
Challenges in Studying Modifiable Risk Factors for Birth Defects.
Curr Epidemiol Rep. 2015 Mar;2(1):23-30. doi: 10.1007/s40471-014-0028-y.
7
Adjusting for bias due to incomplete case ascertainment in case-control studies of birth defects.
Am J Epidemiol. 2015 Apr 15;181(8):595-607. doi: 10.1093/aje/kwu323. Epub 2015 Mar 19.
8
Congenital Malformations and Consequential Epidemiology.
Curr Epidemiol Rep. 2015 Mar;2(1):8-12. doi: 10.1007/s40471-014-0029-x.
9
Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects.
Birth Defects Res A Clin Mol Teratol. 2013 Aug;97(8):515-31. doi: 10.1002/bdra.23137. Epub 2013 May 28.

本文引用的文献

1
Maternal treatment with opioid analgesics and risk for birth defects.
Am J Obstet Gynecol. 2011 Apr;204(4):314.e1-11. doi: 10.1016/j.ajog.2010.12.039. Epub 2011 Feb 23.
2
Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System.
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S64-8. doi: 10.1016/j.ajog.2011.01.047. Epub 2011 Feb 18.
3
Selected birth defects data from population-based birth defects surveillance programs in the United States, 2003-2007.
Birth Defects Res A Clin Mol Teratol. 2010 Dec;88(12):1062-174. doi: 10.1002/bdra.20760.
4
Asthma in pregnancy and its pharmacologic treatment.
Ann Allergy Asthma Immunol. 2010 Aug;105(2):110-7. doi: 10.1016/j.anai.2010.05.016.
5
Pregnancy associated smoking behavior and six year postpartum recall.
Matern Child Health J. 2009 Nov;13(6):865-72. doi: 10.1007/s10995-008-0417-2. Epub 2008 Sep 26.
6
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies.
Birth Defects Res A Clin Mol Teratol. 2007 Oct;79(10):714-27. doi: 10.1002/bdra.20403.
7
Prepregnancy obesity as a risk factor for structural birth defects.
Arch Pediatr Adolesc Med. 2007 Aug;161(8):745-50. doi: 10.1001/archpedi.161.8.745.
9
Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure.
Pharmacoepidemiol Drug Saf. 2006 Jan;15(1):39-45. doi: 10.1002/pds.1134.
10
Proper interpretation of non-differential misclassification effects: expectations vs observations.
Int J Epidemiol. 2005 Jun;34(3):680-7. doi: 10.1093/ije/dyi060. Epub 2005 Mar 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验